These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9449168)

  • 1. Effects of topical antiandrogen and 5-alpha-reductase inhibitors on sebaceous glands in male fuzzy rats.
    Ye F; Imamura K; Imanishi N; Rhodes L; Uno H
    Skin Pharmacol; 1997; 10(5-6):288-97. PubMed ID: 9449168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity.
    Chen C; Puy LA; Simard J; Li X; Singh SM; Labrie F
    J Invest Dermatol; 1995 Nov; 105(5):678-82. PubMed ID: 7594643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse.
    Park WS; Lee CH; Lee BG; Chang IS
    J Dermatol Sci; 2003 Apr; 31(2):91-8. PubMed ID: 12670719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.
    Imperato-McGinley J; Gautier T; Cai LQ; Yee B; Epstein J; Pochi P
    J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.
    Chen W; Zouboulis CC; Orfanos CE
    Dermatology; 1996; 193(3):177-84. PubMed ID: 8944337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17 alpha-Propylmesterolone (SH 434): an antiandrogenic sebosuppressive substance not influencing circulating testosterone concentrations. Experimental studies in Syrian hamsters.
    Luderschmidt C; Eiermann W; Jawny J; Bidlingmaier F; Ring J
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):214-8. PubMed ID: 6527707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topically applied antiandrogenic compounds on sebaceous glands of hamster ears and flank organs.
    Schröder HG; Ziegler M; Nickisch K; Kaufmann J; el Etreby MF
    J Invest Dermatol; 1989 May; 92(5):769-73. PubMed ID: 2715647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of 17beta-(N-alkyl/arylformamido) and 17beta-[(N-alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors in the hamster flank organ and ear.
    Chen C; Li X; Singh SM; Labrie F
    J Invest Dermatol; 1998 Aug; 111(2):273-8. PubMed ID: 9699729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.
    Prahalada S; Rhodes L; Grossman SJ; Heggan D; Keenan KP; Cukierski MA; Hoe CM; Berman C; van Zwieten MJ
    Prostate; 1998 May; 35(3):157-64. PubMed ID: 9582084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a nonsteroid antiandrogen, flutamide, on sebaceous gland activity.
    Lutsky BN; Budak M; Koziol P; Monahan M; Neri RO
    J Invest Dermatol; 1975 Jun; 64(6):412-7. PubMed ID: 1141714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a new topically active antiandrogen (RU 38882) on the rat sebaceous gland: comparison with cyproterone acetate.
    Bouton MM; Lecaque D; Secchi J; Tournemine C
    J Invest Dermatol; 1986 Feb; 86(2):163-7. PubMed ID: 2943819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGP 53153: a new potent inhibitor of 5alpha-reductase.
    Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin.
    Thiboutot D; Harris G; Iles V; Cimis G; Gilliland K; Hagari S
    J Invest Dermatol; 1995 Aug; 105(2):209-14. PubMed ID: 7636302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical anti-androgenicity of a new 4-azasteroid in the hamster.
    Brooks JR; Primka RL; Berman C; Krupa DA; Reynolds GF; Rasmusson GH
    Steroids; 1991 Aug; 56(8):428-33. PubMed ID: 1788861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.